1934-93-6

Basic information

• Product Name: 1,2,3,4-Tetrahydro-1-(4-methoxybenzyl)-6,7-dimethoxy-2-methylisoquinoline
• Synonyms: 1-(4-Methoxybenzyl)-2-methyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline;1,2,3,4-Tetrahydro-1-(4-methoxybenzyl)-6,7-dimethoxy-2-methylisoquinoline;1,2,3,4-Tetrahydro-6,7-dimethoxy-1-(4-methoxybenzyl)-2-methylisoquinoline;6,7-Dimethoxy-1-(4-methoxybenzyl)-2-methyl-1,2,3,4-tetrahydroisoquinoline;O-Methylarmepavine
• CAS NO: 1934-93-6
• Molecular Formula: C₂₀H₂₅NO₃
• Molecular Weight: 327.42
• Mol File: 1934-93-6.mol
• Article Data: 11

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1,2,3,4-Tetrahydro-1-(4-methoxybenzyl)-6,7-dimethoxy-2-methylisoquinoline(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2,3,4-Tetrahydro-1-(4-methoxybenzyl)-6,7-dimethoxy-2-methylisoquinoline(1934-93-6)
• EPA Substance Registry System: 1,2,3,4-Tetrahydro-1-(4-methoxybenzyl)-6,7-dimethoxy-2-methylisoquinoline(1934-93-6)

Safety Data

• Hazardous Substances Data: 1934-93-6(Hazardous Substances Data)

Usage

Description

1,2,3,4-Tetrahydro-1-(4-methoxybenzyl)-6,7-dimethoxy-2-methylisoquinoline, also known as AMMI, is a complex chemical compound belonging to the isoquinoline alkaloid family. It is derived from plants and features multiple functional groups that contribute to its potential pharmacological activities. AMMI has been studied for its anti-inflammatory, analgesic, and neuroprotective properties, making it a promising candidate for pharmaceutical research and drug development.

Uses

Used in Pharmaceutical Research:
AMMI is used as a subject of pharmaceutical research for its potential medicinal uses. Its anti-inflammatory, analgesic, and neuroprotective properties make it a valuable target for the development of new drugs.
Used in Drug Development:
In the field of drug development, AMMI is utilized as a compound with potential applications in creating medications that address inflammation, pain, and neurodegenerative conditions. Further studies are necessary to fully understand its capabilities and optimize its use in medicinal formulations.

Upstream product

• 3991-23-9 6,7-dimethoxy-1-(4-methoxy-benzyl)-2-methyl-3,4-dihydro-isoquinolinium; iodide 
• 30045-07-9 2-methyl-6,7-dimethoxy-3,4-dihydroisoquinolinium iodide 
• 2746-25-0 p-Methoxybenzyl bromide 
• 186581-53-3 diazomethane 
• 50-00-0 formaldehyd 
• 41498-37-7 7,12-O,O'-dimethylcoclaurine 
• 1472-62-4 N-methylcoclaurine 
• 72527-29-8 6,7-dimethoxy-1-(4-methoxybenzyl)-3,4-dihydroisoquinoline 
• 1253195-04-8 6-demethyl-4'-O-methyl-N-methylcoclaurine 
• 1246431-54-8 C₁₈H₁₅Cl₃O₆ 
• 1580442-44-9 methyl 2-{4-hydroxy-3-[4-(2-methoxy-2-oxoethyl)phenoxy]phenyl}acetate 
• 42583-41-5 2-{4-[5-(carboxymethyl)-2-methoxyphenoxy]phenyl}acetic acid 
• 114105-51-0 (S)-(-)-[2-(3,4-dimethoxyphenyl)ethyl](1-phenylethyl)amine 
• 409366-27-4 (3,5-dichloro-4-hydroxyphenyl)acetic acid methyl ester 

Downstream Products

• 308803-66-9 (E)-methyl N-[2-(4,5-dimethoxy-2-[2-(4-methoxyphenyl)ethenyl]phenyl)ethyl]-N-methylcarbamate 
• 102759-47-7 polysignine 
• 308803-68-1 methyl N-[2-(4,5-dimethoxy-2-[2-(4-methoxyphenyl)ethyl]phenyl)ethyl]-N-methylcarbamate 
• 35854-35-4 4-[(4-methoxyphenyl)methyl]pyridine 

Relevant articles and documents

Light-Induced Alkylation of (Hetero)aromatic Nitriles in a Transition-Metal-Free C-C-Bond Metathesis

A light-induced C-C-σ-bond metathesis was achieved through transition-metal-free activation of an unstrained C(sp3)-C(sp3)-σ-bond in 1-benzyl-1,2,3,4-tetrahydroisoquinolines. A photoredox-mediated single-electron oxidation of these precursor amines yield radical cations which undergo a homolytic cleavage of a C(sp3)-C(sp3)-σ-bond rather than the well-known α-C-H-scission. The resulting carbon-centered radicals are used in the ipso-substitution of (hetero)aromatic nitriles proceeding through another single-electron transfer-mediated C-C-bond cleavage and formation.

Synthesis of (+)-O-methylthalibrine by employing a stereocontrolled Bischler-Napieralski reaction and an electrochemically generated diaryl ether

An efficient electrochemical four-step route was developed for the preparation of diaryl ether derivatives by using halogenation and dehalogenation processes in addition to electrochemical phenolic oxidation and reduction reactions. The synthesis of (+)-O

Method and health food for preventing and/or alleviating psychiatric disorder, and/or for effectuating sedation

A method for preventing and/or alleviating a psychiatric disorder, and/or effectuating sedation, comprising administering a benzylisoquinoline derivative represented by General Formula (I): wherein R1, R2, R3 and X each re